Candice Stevens, APRN
Acute Care · Ashland, KYNPI 1093243446
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,850 of the $5,421 with a category attached, or 71.0%. It is spread thinly across 49 manufacturers, the largest accounting for just 9.9%. 2025 is the largest year on record at $2,577, 4.5 times the $569 reported in 2021. Among acute care clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $27.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$534
- Johnson & Johnson$439
- AbbVie$357
- Pfizer$352
- Seagen Inc.$316
- Incyte Corporation$287
- plus $3K from 43 others
What the payments were for
- Food & beverage$3,85071%
- Education$1,57029%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,421 in reported general payments places this provider in the 95th percentile of 319 acute care providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImbruvicaIbrutinib | 24 | $388,194 |
| TasignaNilotinib Hcl | 22 | $333,487 |
| VenclextaVenetoclax | 20 | $307,095 |
| IbrancePalbociclib | 17 | $277,130 |
| NubeqaDarolutamide | 11 | $140,658 |
| Imatinib Mesylate | 36 | $78,803 |
| Abiraterone Acetate | 16 | $45,386 |
| XareltoRivaroxaban | 37 | $31,987 |
| Promethazine Hcl | 24 | $5,087 |
| Potassium Chloride | 94 | $2,108 |
| Ondansetron OdtOndansetron | 64 | $1,940 |
| Anastrozole | 90 | $1,521 |
| Hydroxyurea | 45 | $1,414 |
| Levofloxacin | 35 | $491 |
| Methylprednisolone | 22 | $376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Pharmacyclics LLC, An Abbvie CompanyImbruvica | $120 | $388,19424 claims |
| NovartisTasigna | $264 | $333,48722 claims |
| AbbVieVenclexta | $357 | $307,09520 claims |
| PfizerIbrance | $352 | $277,13017 claims |
| BayerNubeqa | $22 | $140,65811 claims |
| Johnson & JohnsonXarelto | $439 | $31,98737 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 319 acute care providers in Kentucky.
Other acute care in Ashland
- Anna BayesAshland$7K
- Brittany ShortAshland$6K
- Pamela ParkerAshland$4K
- Caitlin ArthurAshland$2K
- Shannon AtkinsonBowling Green$63K
- Billie WaltersLexington$20K
- Audra MarcumLexington$14K
- Holly ChitwoodLexington$10K
- Vanessa PaddyElizabethtown$8K
- Baylee KnoxGlasgow$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.